The Covid-19 pandemic, responsible for over 6 million worldwide deaths, there was an urgent need for preventative measures to mitigate its effects. Conventional vaccines, which typically prevent or reduce disease severity, usually require more than a decade for development and commercialization. The pressing nature of the pandemic led to the pursuit of novel solutions like mRNA-based vaccines, playing a critical role in saving lives. This article highlights the potential of mRNA technology to go beyond infectious diseases, offering the possibility to change the treatment landscape of future malignant diseases and address unmet medical needs.
HTML PDFShare this article
